Home
 /
Papers
 /
Genetics
 /
Xist Repeat A coordinates an assembly of SR proteins to recruit SPEN and induce gene silencing
Preprint
Open access
V1
Top 1% · Validated by QED

Xist Repeat A coordinates an assembly of SR proteins to recruit SPEN and induce gene silencing

Jackson B. Trotman, Alessandro Porrello, Scott A. Schactler +17 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.1101/2025.05.21.655143
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genetics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By showing that SR-rich splicing factors bridge SPEN to Xist's Repeat A, this work overturns a core assumption in X-inactivation and establishes SR-protein sensing as a general mechanism for lncRNA-mediated transcriptional repression.

QED claims analysis

Summary

Xist recruits the silencing protein SPEN through a mechanism in which SR splicing factors, particularly SRSF1, bind to GC-rich motifs in Repeat A and serve as bridging adaptors that enable SPEN's N-terminus to recognize SR-protein-rich assemblies, thereby coordinating interactions with the m6A methylation, RNA turnover, and transcriptional elongation machineries to induce gene silencing—a general regulatory mechanism that SPEN also employs genome-wide to repress autosomal genes bearing similar SR-protein-enriched RNA features.

See full analysis
Main Claim 1 –

Repeat A GC-rich cores control Xist silencing, production, splicing

Supporting evidence

  • Repeat A binds SR proteins via GC-core motifs
Main Claim 2 –

In vivo SPEN–Repeat A association requires noncanonical sequences

Supporting evidence

  • SPEN N-terminus binds SR proteins and nuclear speckle factors
Main Claim 3 –

SRSF1 binds Repeat A motif to recruit SPEN

Supporting evidence

  • SPEN and SR motifs link Repeat A to m6A, exosome, elongation
  • SPEN represses autosomal transcription via Repeat A-like RNP features

Abstract

The lncRNA Xist represents a paradigm to understand the mechanisms of RNA-mediated gene silencing in mammals, which remain largely unresolved. To induce silencing, Xist recruits the RNA-binding protein SPEN through its 5′-proximal Repeat A domain. Yet, how Repeat A recruits SPEN and how SPEN coordinates silencing remain unclear. We report that sequences in Repeat A critical for SPEN recruitment directly bind SR-rich splicing factors. SRSF1, one such factor, is required for optimal SPEN recruitment and its RS-domain recruits SPEN when tethered to Xist. SPEN and SR-protein-binding motifs promote Repeat A’s association with many proteins, including the m6A machinery and elongating RNA polymerase II. SPEN also represses autosomal genes where its recruitment coincides with SR-protein binding. Our results reveal an unexpectedly essential role for splicing factors in coordinating silencing by Xist and suggest that the sensing of SR-protein-rich assemblies is a general mechanism through which SPEN targets genes for repression.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?